Novel 21-Aminosteroids that Inhibit Iron-Dependent Lipid Peroxidation and Protect against Central Nervous System Trauma

E. Jon Jacobsen, John M. McCall, Donald E. Ayer, Fred J. VanDoornik, John R. Palmer, Kenneth L. Belonga, J. Mark Braughler, Edward D. Hall, David J. Houser, Mark A. Krook, Thomas A. Runge

Research output: Contribution to journalArticlepeer-review

107 Scopus citations

Abstract

A novel class of 21-aminosteroids has been developed. Compounds within this series are potent inhibitors of iron-dependent lipid peroxidation in rat brain homogenates with IC50's as low as 3 μM. Furthermore, selected members enhance early neurological recovery and survival in a mouse head injury model. Significant improvement in the 1 h post-head-injury neurological status (grip test score) by as much as 168.6% of the control has been observed. The most efficacious compound in this assay (30) showed an increase in the 1-week survival of 78.6% as compared to 27.3% for the vehicle-treated mice in the head-injury model. Based on its biological profile, 21-[4-(2,6-di-1- pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl]-16α-methylpregna-1,4,9(11)-triene-3,20-dione monomethanesulfonate (30) was selected for further evaluation and is currently entering phase I clinical trials for the treatment of head and spinal trauma.

Original languageEnglish
Pages (from-to)1145-1151
Number of pages7
JournalJournal of Medicinal Chemistry
Volume33
Issue number4
DOIs
StatePublished - Apr 1990

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Novel 21-Aminosteroids that Inhibit Iron-Dependent Lipid Peroxidation and Protect against Central Nervous System Trauma'. Together they form a unique fingerprint.

Cite this